Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Journal of Drug Targeting
|
December 29, 2004
Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation
K Ulbrich, T Etrych, P Chytil, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 2, 2002
HPMA-hydrogels result in prolonged delivery of anticancer drugs and are a promising tool for the treatment of sensitive and multidrug resistant leukaemia
M St'astný, D Plocová, T Etrych, et al.
FEBS Letters
|
November 24, 1999
Characterisation of the binding interaction between poly(L-lysine) and DNA using the fluorescamine assay in the preparation of non-viral gene delivery vectors
M L Read, T Etrych, K Ulbrich, et al.
Physiological Research
|
October 21, 2016
Intracellular fate of polymer therapeutics investigated by fluorescence lifetime imaging and fluorescence pattern analysis
J Panek, E Koziolova, P Stepanek, et al.
International Journal of Pharmaceutics
|
May 26, 2004
Polymeric anticancer drugs with pH-controlled activation
K Ulbrich, T Etrych, P Chytil, et al.
Physiological Research
|
October 9, 2015
Nanotherapeutics with anthracyclines: methods of determination and quantification of anthracyclines in biological samples
E Koziolova, O Janouskova, P Chytil, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 13, 2005
Oligopeptides as targeting structures in cancer theraPY
M Pechar, K Ulbrich, T Etrych, et al.
Physiological Research
|
October 9, 2015
The comparison of in vivo properties of water-soluble HPMA-based polymer conjugates with doxorubicin prepared by controlled RAFT or free radical polymerization
P Chytil, M Šírová, E Koziolová, et al.
Current Medicinal Chemistry
|
October 3, 2013
HPMA copolymer-bound doxorubicin induces immunogenic tumor cell death
M Sirova, M Kabesova, L Kovar, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 22, 2003
HPMA copolymer-bound doxorubicin targeted to tumor-specific antigen of BCL1 mouse B cell leukemia
M Kovár, T Mrkvan, J Strohalm, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Journal of Drug Targeting
|
December 29, 2004
Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation
K Ulbrich, T Etrych, P Chytil, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 2, 2002
HPMA-hydrogels result in prolonged delivery of anticancer drugs and are a promising tool for the treatment of sensitive and multidrug resistant leukaemia
M St'astný, D Plocová, T Etrych, et al.
FEBS Letters
|
November 24, 1999
Characterisation of the binding interaction between poly(L-lysine) and DNA using the fluorescamine assay in the preparation of non-viral gene delivery vectors
M L Read, T Etrych, K Ulbrich, et al.
Physiological Research
|
October 21, 2016
Intracellular fate of polymer therapeutics investigated by fluorescence lifetime imaging and fluorescence pattern analysis
J Panek, E Koziolova, P Stepanek, et al.
International Journal of Pharmaceutics
|
May 26, 2004
Polymeric anticancer drugs with pH-controlled activation
K Ulbrich, T Etrych, P Chytil, et al.
Physiological Research
|
October 9, 2015
Nanotherapeutics with anthracyclines: methods of determination and quantification of anthracyclines in biological samples
E Koziolova, O Janouskova, P Chytil, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 13, 2005
Oligopeptides as targeting structures in cancer theraPY
M Pechar, K Ulbrich, T Etrych, et al.
Physiological Research
|
October 9, 2015
The comparison of in vivo properties of water-soluble HPMA-based polymer conjugates with doxorubicin prepared by controlled RAFT or free radical polymerization
P Chytil, M Šírová, E Koziolová, et al.
Current Medicinal Chemistry
|
October 3, 2013
HPMA copolymer-bound doxorubicin induces immunogenic tumor cell death
M Sirova, M Kabesova, L Kovar, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 22, 2003
HPMA copolymer-bound doxorubicin targeted to tumor-specific antigen of BCL1 mouse B cell leukemia
M Kovár, T Mrkvan, J Strohalm, et al.
Page
of 4